Navigation Links
When positive thinking leads to financial irresponsibility like compulsive gambling
Date:4/21/2008

Looking on the bright side can lead to irresponsible financial behavior, reveals a paper from the June 2008 issue of the Journal of Consumer Research. In a series of studies, Elizabeth Cowley (University of Sydney) examines repeat gambling in the face of loss. She finds that people often engage in too much positive thinking, selectively focusing on one win among hundreds of losses when they think back on the overall experience.

When we want to justify engaging in an activity which could potentially be irresponsible like gambling we may need to distort our memory of the past to rationalize the decision, Cowley explains. People who have frequently spent more money than planned on gambling edit their memories of the past in order to justify gambling again.

For example, Cowley had participants in one study play a computer game in which they could win credits with the financial equivalent of one cent per credit. Each participant played the game 300 times. Everyone experienced one big win and one big loss. But for the other 298 games, one half of the group experienced all small losses, while the other experienced all small wins.

Cowley also manipulated the distance between the big win and the big loss.

A week later, participants were surveyed for their memories of the experience. Surprisingly, Cowley found that even some losers remembered having a positive experience. If the big win and the big loss occurred far apart, losers had fond memories and indicated a willingness to spend their own money on the game.

As Cowley explains, the further apart the big win and the big loss, the easier it was for losers to isolate their memories and focus only on the positive, a silver lining effect.

The tendency to segregate positive and negative events in a mixed-loss experience is based on the logic that remembering a large gain allows people to feel good even when the objective outcome was negative, Cowley says.

C
'/>"/>

Contact: Suzanne Wu
swu@press.uchicago.edu
209-608-2038
University of Chicago Press Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
3. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
4. Nutrition model stresses positive experience of eating
5. Ultrasound plus mammography finds more cancers, but increases false positives
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
8. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
9. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
10. A low prevalence of H pylori in HIV-positive patients
11. Drug Company-Funded Asthma Drug Studies More Positive
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 3Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 3Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 3Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 1BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 4Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 1Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 2Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 3CBI Hosts Life Sciences Summit on International Trade Compliance 14047 1CBI Hosts Life Sciences Summit on International Trade Compliance 14047 2